PRXV vs. SMRI
PRXV (Praxis Impact Large Cap Value ETF) and SMRI (Bushido Capital US Equity ETF) are both Large Cap Value Equities funds. Both are actively managed. Their 0.40 correlation means their historical movements had little consistent relationship. PRXV charges 0.36%/yr vs 0.71%/yr for SMRI.
Performance
PRXV vs. SMRI - Performance Comparison
Loading charts...
Returns By Period
PRXV
- 1D
- -0.34%
- 1M
- 0.88%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
SMRI
- 1D
- 0.38%
- 1M
- 5.51%
- 6M
- 23.61%
- YTD
- 23.03%
- 1Y
- 40.59%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 22.95%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $979.94K | $510.04K | $263.55K | |
| $770.42K | $508.81K | $403.01K |
PRXV vs. SMRI - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
PRXV Praxis Impact Large Cap Value ETF | 8.89% |
SMRI Bushido Capital US Equity ETF | 18.31% |
Correlation
The correlation between PRXV and SMRI is 0.40, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 20, 2026 | 0.40 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRXV vs. SMRI — Risk / Return Rank
PRXV
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
SMRI
PRXV vs. SMRI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Praxis Impact Large Cap Value ETF (PRXV) and Bushido Capital US Equity ETF (SMRI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRXV | SMRI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.47 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 5.75 | — |
| Martin ratioReturn relative to average drawdown | — | 16.88 | — |
Loading charts...
Drawdowns
PRXV vs. SMRI - Drawdown Comparison
The maximum PRXV drawdown since its inception was -1.41%, smaller than the maximum SMRI drawdown of -18.45%. Use the drawdown chart below to compare losses from any high point for PRXV and SMRI.
Loading charts...
Drawdown Indicators
| PRXV | SMRI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -1.41% | -18.45% | +17.04% |
Max Drawdown (1Y)Largest decline over 1 year | — | -6.80% | — |
Current DrawdownCurrent decline from peak | -1.24% | -0.51% | -0.73% |
Average DrawdownAverage peak-to-trough decline | -0.39% | -2.72% | +2.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.32% | — |
Volatility
PRXV vs. SMRI - Volatility Comparison
Loading charts...
Volatility by Period
| PRXV | SMRI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 3.61% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 11.80% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 10.08% | 15.09% | -5.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 10.08% | 15.84% | -5.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 10.08% | 15.84% | -5.76% |
PRXV vs. SMRI - Expense Ratio Comparison
PRXV has a 0.36% expense ratio, which is lower than SMRI's 0.71% expense ratio.
Dividends
PRXV vs. SMRI - Dividend Comparison
PRXV's dividend yield for the trailing twelve months is around 0.38%, less than SMRI's 0.86% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
PRXV Praxis Impact Large Cap Value ETF | 0.38% | 0.00% | 0.00% | 0.00% |
SMRI Bushido Capital US Equity ETF | 0.86% | 1.32% | 0.98% | 0.45% |
Frequently Asked Questions
PRXV and SMRI have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PRXV is cheaper at 0.36% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PRXV is cheaper with a 0.36% expense ratio, compared with 0.71% for SMRI.
SMRI has the higher dividend yield at 0.86%, compared with 0.38% for PRXV.
They also come from different issuers: Praxis and Bushido. Their fees differ too: 0.36% for PRXV and 0.71% for SMRI.
Find the right allocation for PRXV and SMRI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer